Showing results (181-190 of 240) with videos related to
Sort By:
Pageof 24
Chest|April 30, 2018
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY TrialKelly M Chin, Mardi Gomberg-Maitland, Richard N Channick, et al.Circulation|December 31, 2011
Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantationYan Topilsky, Tal Hasin, Eugenia Raichlin, et al.The American Journal of Cardiology|July 24, 2012
Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survivalTal Hasin, Yan Topilsky, Walter K Kremers, et al.Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.Transplantation|February 1, 2013
Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationYan Topilsky, Eugenia Raichlin, Tal Hasin, et al.Pulmonary Circulation|November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertensionRobert P Frantz, Raymond L Benza, Richard N Channick, et al.Journal of the American College of Cardiology|December 11, 2012
Readmissions after implantation of axial flow left ventricular assist deviceTal Hasin, Yariv Marmor, Walter Kremers, et al.The American Journal of Cardiology|September 8, 2014
Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failureTal Hasin, Sudhir S Kushwaha, Timothy G Lesnick, et al.European Journal of Heart Failure|July 26, 2024
Non-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertensionYogesh N V Reddy, Hilary Dubrock, Paul M Hassoun, et al.Pageof 24